<DOC>
	<DOCNO>NCT01282801</DOCNO>
	<brief_summary>The objective study compare rate extent absorption venlafaxine hydrochloride 150 mg extended-release capsule ( test ) versus EffexorÂ® XR ( reference ) administer 1 x 150 mg extended-release capsule feed condition .</brief_summary>
	<brief_title>Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Members community large . Subjects females and/or male , nonsmoker , 18 year age old . Female subject postmenopausal surgically sterilize . Clinically significant illness within 4 week administration study medication . Clinically significant surgery within 4 week prior administration study medication . Any clinically significant abnormality find medical screening . Any history presence significant neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric metabolic disease . History presence clinically significant gastrointestinal pathology , unresolved gastrointestinal symptom , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug . Subjects raise intraocular pressure risk acute narrow angle glaucoma . Subjects predispose bleed skin mucous membrane . Subjects history seizure . Any reason , opinion medical subinvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Positive urine drug screen screen . Positive test hepatitis B , hepatitis C , HIV screen . ECG abnormality ( clinically significant ) vital sign abnormality screen . Subjects BMI &gt; 30.0 . History significant alcohol abuse within six month screen visit indication regular use fourteen unit alcohol per week ( 1 unit equal 150 mL wine , 360 mL beer , 45 mL alcohol 45 % ) . History drug abuse use illegal drug : use soft drug ( marijuana ) within 3 month screen visit hard drug ( cocaine , PCP , crack ) within 1 year screen visit . Any food allergy , intolerance , restriction , special diet , opinion medical subinvestigator , contraindicate subject 's participation study . History allergic reaction venlafaxine hydrochloride . History allergic reaction heparin . Use drug know induce inhibit hepatic drug metabolism , use investigational drug , participation investigational study within 30 day prior administration study medication . Use prescription medication within 14 day prior administration study medication overthecounter product within 7 day prior administration study medication , except topical product without systemic absorption . Subjects depot injection implant drug 3 month prior administration study medication . Donation plasma ( 500 mL ) within 7 day Period I dose . Donation loss whole blood prior administration study medication follow : less 300 mL whole blood within 30 day 300 mL 500 mL whole blood within 45 day 500 mL whole blood within 56 day . Positive alcohol breath test screening . Subjects use tobacco form within 90 day precede study drug administration . Subjects consume food beverage contain grapefruit within 7 day prior administration study medication . Intolerance venipuncture . Additional exclusion criterion female : Breastfeeding subject . Positive urine pregnancy test screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>